Nantong Diagnose Biotechnology

Nantong Diagnos Biotechnology is a China-based in vitro diagnostics and point-of-care testing manufacturer focused on the development, production, and distribution of rapid diagnostic tests and related medical instruments. The company markets products across fertility, infectious disease, cardiac marker, tumor marker, drugs-of-abuse, alcohol, urinalysis, and fluorescence immunochromatography testing categories. Its product portfolio includes both colloidal gold rapid tests and fluorescence-based quantitative assays such as 25-OH vitamin D, D-dimer, C-reactive protein, serum amyloid A, ferritin, calcitonin, and glycated hemoglobin tests. Diagnos appears to operate as a commercial-stage diagnostics supplier with export activity across Southeast Asia, Africa, the Middle East, and Europe, supported by ISO 9001, ISO 13485, and CE-marked products.